Ciclosporin - Cellgate
Alternative Names: CGC 1072; CGC 1072 analogue - Cellgate; CGC 2001; Cyclosporin modified - Cellgate; Cyclosporine modified - Cellgate; PsorBanLatest Information Update: 02 Oct 2021
At a glance
- Originator Cellgate
- Class Anti-inflammatories; Antineoplastics; Antipsoriatics; Antirheumatics; Ciclosporins; Eye disorder therapies; Heart failure therapies; Neuroprotectants
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Psoriasis
Most Recent Events
- 09 Aug 2007 Discontinued - Phase-II for Psoriasis in USA (Topical)
- 05 May 2003 Clinical data from a media release have been added to the pharmacokinetics and the Skin Disorders and Drug Delivery Systems therapeutic trials sections
- 09 Apr 2003 Data presented at the 61st Annual Meeting of the American Academy of Dermatology (AAD-2003) have been added to the adverse events and Skin Disorders and Drug Delivery Systems therapeutic trials sections